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Th17 cells are most abundant in the gut, where their
presence depends on the intestinal microbiota. Here,
we examinedwhether intestinal Th17 cells contribute
to extra-intestinal Th17 responses in autoimmune
kidney disease. We found high frequencies of Th17
cells in the kidneys of patients with antineutrophil
cytoplasmatic antibody (ANCA)-associated glomer-
ulonephritis. We utilized photoconversion of intesti-
nal cells in Kaede mice to track intestinal T cell
mobilization upon glomerulonephritis induction,
and we found that Th17 cells egress from the gut in
a S1P-receptor-1-dependent fashion and subse-
quently migrate to the kidney via the CCL20/CCR6
axis. Depletion of intestinal Th17 cells in germ-free
and antibiotic-treated mice ameliorated renal dis-
ease, whereas expansion of these cells upon Citro-
bacter rodentium infection exacerbated pathology.
Thus, in some autoimmune settings, intestinal Th17
cells migrate into target organs, where they con-
tribute to pathology. Targeting the intestinal Th17
cell ‘‘reservoir’’ may present a therapeutic strategy
for these autoimmune disorders.
INTRODUCTION
CD4+ T cells are critical for defense against a wide array of
invading microbes and pathogens but are also major drivers of
autoimmune diseases. Based on their cytokine secretion profile
and expression of specific transcription factors, CD4+ T cells
can be classified into functionally different subsets, e.g., Th1,1078 Immunity 45, 1078–1092, November 15, 2016 ª 2016 The Auth
This is an open access article under the CC BY license (http://creativeTh2, Th17, and regulatory T cells (Tregs) (O’Shea and Paul,
2010). It was generally accepted that IFN-g-expressing Th1 cells
primarily initiate and perpetuate tissue damage in autoimmunity
(Mosmann et al., 1986). This paradigm was challenged in 2005
by the discovery of a highly pathogenic IL-17-producing CD4+
effector T cell subset, termed Th17 cells (Harrington et al., 2005;
Park et al., 2005). Th17 cells are characterized by their key tran-
scription factors RORgt and STAT3 (Ivanov et al., 2006; Nurieva
et al., 2007), the production of the cytokines IL-17A, IL-17F, IL-
22 and GM-CSF (Codarri et al., 2011; Zenewicz et al., 2007),
and high expression of CCR6 (Acosta-Rodriguez et al., 2007).
Today, their central role in the pathogenesis of several autoim-
mune diseases is clearly established (Gaffen et al., 2014).
Crescentic glomerulonephritis (cGN) is the most aggressive
form of autoimmune kidney diseases that destroys kidneys
over a period of days to weeks, leading to end-stage renal failure
with associated highmorbidity, mortality, and public health costs
(Couser, 2012; Kurts et al., 2013). The infiltration of leukocytes,
including T cells, and the proliferation of resident glomerular cells
lead to the formation of glomerular crescents and a disrupted
anatomical structure of the glomerulus, ultimately leading to
loss of kidney function. Current treatment protocols are unspe-
cific and hampered by toxic side effects that deteriorate patient
outcome.
Recent studies have highlighted the substantial impact of the
Th17 immune response in cGN (Kitching and Holdsworth, 2011;
Kurts et al., 2013). This includes the identification and character-
ization of CCR6+ IL-17-producing T cells in murine kidneys in
experimental models of cGN (Paust et al., 2012; Turner et al.,
2010), as well as evidence for the contribution of IL-17A, IL-
17F, IL-17RA, IL-23p19, and RORgt to renal tissue injury in
cGN (Paust et al., 2009; Ramani et al., 2014; Riedel et al.,
2016; Steinmetz et al., 2011; Summers et al., 2009). Th17-cell-
derived IL-17A and IL-17F promote the expression of chemo-
kines such as CXCL1 and CXCL5 in the kidney and thereby driveors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
recruitment of neutrophils and other leukocyte subtypes, which
mediate renal tissue destruction in cGN (Disteldorf et al., 2015;
Turner et al., 2010). Although we are beginning to understand
the effector functions of Th17 cells in the target tissue, the devel-
opmental origin of Th17 cells that infiltrate inflamed tissues, e.g.,
the kidney in glomerulonephritis, is still a matter of debate.
Under homeostatic conditions, Th17 cells are most abundant
in the small intestinal lamina propria, and their presence in the
gut of mice requires the colonization with specific adhesive mi-
croorganisms (Ivanov et al., 2009). Colonization of mice with
segmented filamentous bacteria (SFB) results in the generation
of SFB-specific Th17 cells (Yang et al., 2014). In addition to
SFB, infection of mice with enterohemorrhagic Escherichia coli
(EHEC) or Citrobacter rodentium results in the expansion of in-
testinal Th17 cells (Atarashi et al., 2015; Ivanov et al., 2009;
Sano et al., 2015). In line with this, germ-free mice lack intestinal
Th17 cells, and antibiotic treatment of mice can reduce intestinal
Th17 cell frequencies (Atarashi et al., 2008; Ivanov et al., 2008;
Rakoff-Nahoum et al., 2004). In addition, Th17 cells from
lymphoid tissues preferentially home to the gut after transfer
and are phenotypically almost indistinguishable from intestinal
Th17 cells (Hirota et al., 2013). Th17 cells highly express
CCR6, which orchestrates their trafficking to the small intestine
(Esplugues et al., 2011) but also to sites of peripheral inflamma-
tion, such as the kidney in glomerulonephritis (Turner et al.,
2010). Furthermore, organ-specific Th17 immune responses in
experimental autoimmune encephalomyelitis (EAE) and arthritis
are diminished in mice with reduced intestinal Th17 cells, i.e.,
in germ-free mice (Lee et al., 2011; Wu et al., 2010). Taken
together, these observations indicate a close relationship of
Th17 cells with the intestinal microbiota. However, the mecha-
nisms bywhichmicrobiota-induced Th17 cells promote extra-in-
testinal Th17 immune responses remain to be fully elucidated.
Here, using transgenic mice that ubiquitously express the
photoconvertible Kaede-protein, we directly demonstrated the
migration of intestinal Th17 cells to the kidney in experimental
cGN. Experiments in microbiota-manipulated mice underscore
the concept of pathogenic Th17 cells migrating from the gut to
the inflamed kidney. Our findings provide evidence supporting
a role for intestinal Th17 cells in the exacerbation of GN and
suggest that migration of intestinal Th17 cells may contribute
to pathology in other autoimmune diseases.
RESULTS
Identification and Characterization of Th17 Cells in the
Kidneys of Patients with ANCA-Associated cGN
Antineutrophil cytoplasmatic antibody (ANCA)-associated GN is
the most common cause of cGN and is characterized by the for-
mation of glomerular crescents (Figure 1A). This is associated
with the infiltration of T cells and neutrophils (Figure 1B). To
determine the composition of T cell subsets in ANCA-associated
GN, we analyzed cells isolated from human renal biopsies by
flow cytometry. The clinical characteristics of ANCA-GN patients
included in this study are summarized in Figure S1. Th17 cells
can be distinguished from other CD4+ T cells via the expression
of the transcription factor RORgt. We identified RORgt+ cells in
the kidneys of patients with ANCA-associated GN (Figures 1C
and 1D). The frequency of renal CD4+RORgt+ T cells was high(about 30%) and increased compared to CD4+ T cells from the
peripheral blood (<3%) of patients with ANCA-GN (Figures 1C–
1E). In control kidney samples derived from tumor nephrec-
tomies, CD4+RORgt+ cells were detected at low frequencies
(<3%, Figures 1E and 1F). RORgt expression by leukocytes iso-
lated from inflamed kidneys was primarily allocated to CD3+
T cells (90%), and the majority of these were CD4+ T helper
cells (Figures 1C and 1G). We recently reported increased
expression of CCR6 and its ligand CCL20 in the kidney of pa-
tients with ANCA-GN (Paust et al., 2015). In line with this finding,
the majority of the CD4+RORgt+ Th17 cells in the kidney and
blood expressed CCR6, supporting a role for this receptor in
Th17 cell trafficking (Figure 1H).
Renal Th17 Cells Have Gut-Homing Properties in
Experimental cGN
To further investigate the function and trafficking properties of
Th17 cells, we used the well-characterized mouse model of
cGN (Bolle´e et al., 2011; Krebs et al., 2013; Pisitkun et al.,
2012; Tsuboi et al., 2008). The cGN model was induced by intra-
peritoneal (i.p.) injection of nephrotoxic sheep serum directed
against the glomerular basementmembrane (GBM). This promp-
ted an adaptive immune response against the planted antigen,
which resulted in the Th17-cell-dependent formation of glomer-
ular crescents, tubulointerstitial injury, and loss of renal function
(Figure 2A), resembling aspects of cGN in humans (Krebs et al.,
2013; Paust et al., 2009; Steinmetz et al., 2011). In this model,
Il17a fate reporter mice (Il17aCre x R26ReYFP) were used to track
Th17 cells (Hirota et al., 2011). CD4+ Th17 cells in the kidney
increased at day 3–5, peaked around day 7–10 after GN induc-
tion, and then declined (Figures 2B and 2C). Importantly, fate-
mapped eYFP+ Th17 cells almost uniformly expressed the signa-
ture cytokine IL-17A (Figure 2D), demonstrating the feasibility of
this reporter system.
To evaluate the trafficking and homing properties of renal Th17
cells compared with other effector T cells, we sorted eYFP+ Th17
cells and eYFP CD4+ T cells with an activated phenotype
(CD44high) from the kidney of nephritic Il17a fate reporter mice
and co-transferred them at a 1:1 ratio into TCRa-deficient hosts
lacking ab+ T cells (Figure 2E). eYFP+ Th17 cells preferentially re-
constituted (or were expanded in) the gut-associated tissues,
such as the small intestinal lamina propria (SILP) and mesenteric
lymph nodes, whereas eYFPCD44high non-Th17 cells were pref-
erentially found in peripheral lymph nodes (Figures 2F and 2G).
We next tested, vice versa, whether gut-derived Th17 cells are
able to migrate to the kidney and, therefore, sorted small intesti-
nal Th17 cells from Il17a fate reporter mice, transferred them into
Tcra/ animals and subsequently induced cGN. As shown in
Figure 2H, gut-derived Th17 cells migrated to the kidney upon
transfer. Moreover, they were sufficient to aggravate GN in
T-cell-deficient animals (Figures 2I–2J).
To further examine the potential relationship of renal and intes-
tinal Th17 cells, we analyzed the sequence of the CDR3 region of
the Tcrb gene of FACS-sorted eYFP+CD44high cells (Th17) and
eYFPCD44high cells (non-Th17) from the kidneys of nephritic
Il17a fate reporter mice and compared those to intestinal Th17
cells sorted from the small intestine of the same mice, using
the ImmunoSEQ platform. As shown in Figures 2K and S2, renal
Th17 cells sharedmore Tcrb sequences with intestinal Th17 cellsImmunity 45, 1078–1092, November 15, 2016 1079
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Figure 1. Identification and Characterization of Th17 Cells in the Kidneys of Patients with ANCA-Associated cGN
(A) PAS staining of a renal biopsy from a patient with ANCA-GN (glomerulus: dashed line; crescent: asterisked).
(B) Consecutive tissue sections were stained for CD3 (T cells) and MPO (neutrophils).
(C) Leukocytes from renal biopsies and peripheral blood samples from ANCA-GN patients were analyzed by flow cytometry.
(D) CD3+CD4+ cells were analyzed for expression of RORgt and CCR6.
(E) Quantification of RORgt+CCR6+ cells of all CD4+ T cells in kidney and blood (ANCA-GN) and control biopsies (unaffected renal tissue of explanted kidneys after
tumor nephrectomy).
(F) Flow cytometry of control biopsies (CD45+ cells).
(G) Quantification of CD45+RORgt+ cells from the kidneys of patients with ANCA-GN as indicated.
(H) CCR6 expression of RORgt+CD4+ T cells from the kidney and peripheral blood (ANCA-GN). Symbols represent individual data points with the mean as a
horizontal line. Scale bar, 30 mm. See also Figure S1.
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Figure 2. Renal Th17 Cells Have Gut-Homing Properties
(A) PAS and CD3 staining of renal tissue sections of mice at day 10 after induction of crescentic glomerulonephritis (cGN). Scale bar, 20 mm.
(B) Intracellular cytokine staining and FACS analyses of CD3+ T cells in the course of cGN (day 0–30).
(C) Quantification of IL-17A+CD4+ Th17 cells in the course of cGN.
(D) Flow cytometry of renal CD4+ T cells from Il17a fate reporter mice (Il17aCre 3 R26ReYFP) and intracellular staining for IL-17A expression.
(E) CD44high Th17 cells (YFP+) and CD44high non-Th17 cells (YFP) were FACS sorted from the kidneys of Il17a fate reporter mice with cGN. Cells were mixed in a
1:1 ratio and transferred into Tcra/ recipients.
(F and G) After 12 weeks, small intestinal lamina propria (SILP), mesenteric lymph nodes (mln), and inguinal lymph nodes (iln) were analyzed for the abundance of
Th17 cells (YFP+) and non-Th17 cells (YFP) by flow cytometry.
(H) Transfer of FACS-sorted Th17 cells (CD44highYFP+) from the small intestine of Il17a fate reporter mice into Tcra/ recipients and cGN induction 5 weeks after
cell transfer. At day 8 after cGN induction, the kidneys were analyzed for gut-derived Th17 cells.
(I and J) (I) PAS-stained kidney sections and (J) quantification of renal damage of mice after Th17 cell transfer and subsequent cGN induction.
(K) cGN was induced in Il17a fate reporter mice. At day 10, renal Th17 cells (YFP+), renal non-Th17 cells (YFP), and small-intestinal Th17 cells were FACS sorted
and analyzed for TCRb sequences using the ImmunoSEQ platform. Common sequences of intestinal Th17 and renal Th17 or renal non-Th17 cells were
calculated. Error bars indicate SEM.
See also Figure S2. Data are representative of at least two independent experiments. Symbols represent individual data points with the mean as a horizontal line,
bars represent mean values. *p < 0.05, **p < 0.01.
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than with renal non-Th17 cells. Thus, gut and kidney Th17 cells
might be reactive to identical antigens. However, further studies
are clearly needed to characterize the antigen specificity of renal
and gut Th17 in cGN. This is currently hampered by the lack of
well-characterized CD4+ T cell epitopes in the cGN model.
Taken together, these data provide first evidence for the rela-
tionship of intestinal and renal Th17 cells and suggest the poten-
tial migration of Th17 cells from the small intestine into the kidney
in crescentic glomerulonephritis.
Th17 Cells in Glomerulonephritis Migrate from the
Intestine into the Kidney
To investigate the potential migration of T cells from the small in-
testine into the kidney in glomerulonephritis, we used mice engi-
neered to ubiquitously express Kaede (Tomura et al., 2010).
Kaede is a photoconvertible protein, which permanently changes
its fluorescence emission from green (518 nm) to red (582 nm)
upon photoactivation with near-UV light (350–410 nm). After
selective exposure of the small intestine for 60 s, Kaede-photo-
conversion was specific to cells in the small intestine (Figure S3).
Next, we induced cGN in Kaede-transgenic mice and photo-
converted intestinal cells at day four (Figure 3A). At day seven,
confocal microscopy of kidney sections revealed the presence
of Kaede red+ cells in the tubulointerstitial area (Figure 3B).
Furthermore, migration of Kaede red+ cells into the inflamed kid-
ney could be detected by flow cytometry, whereas under non-
nephritic conditions, no significant migration of Kaede red+ cells
was present (Figures 3C and 3D). Besides, intravascular staining
using an anti-CD45 antibody 3 min before nephrectomy allowed
the discrimination between tissue-localized and intravascular
blood cells (Anderson et al., 2014) and demonstrated that Kaede
red+ cell were indeed located within the inflamed kidney (Fig-
ure S3), ruling out a contamination by circulating blood cells.
Most importantly, the percentage of IL-17A-positive cells was
significantly higher in gut-derived Kaede red+ cells as compared
to Kaede green+ cells (Figures 3C and 3D), demonstrating the
preferential migration of Th17 cells from the intestine into the in-
flamed kidney. In contrast, IFN-g-expressing Th1 cells were un-
derrepresented in renal Kaede red+ cells (Figure 3D). There was
also no accumulation of IL-17A-producing gd T cells among
Kaede red+ cells (Figures 3E and 3F), supporting the idea that
gd T cells reside in the target organ.
Th17 Cell Egress from the Small Intestine Is Dependent
on S1P Receptor 1
The trafficking of Th17 cells from the intestine into the kidney re-
quires the egress from the small intestinal lamina propria into the
lymphatics. The mechanisms of T cell egress from extralym-
phoid tissue, in particular under inflammatory conditions, are
poorly defined. It has been suggested that potential ‘‘exit recep-
tors,’’ such as CCR7 and the S1P receptor 1, might promote
T cell egress, whereas ‘‘retention signals,’’ e.g., CD103, might
exert the opposite effect.
Flow cytometry of eYFP+ Th17 cells from the small intestine of
nephritic Il17aCre 3 R26ReYFP mice showed almost uniform sur-
face expression of the activation marker CD44 and a high level of
CD69 and CCR6 expression, whereas CD103 and CCR7 were
hardly detectable (Figures 4A–4C). Due to the lack of suitable
FACS antibodies for the S1P receptor 1, we sorted Th17 cells1082 Immunity 45, 1078–1092, November 15, 2016from the small intestine of nephritic and non-nephritic Il17a fate
reporter mice and performed RT-PCR analysis. Interestingly, in-
testinal Th17 cells upregulated the mRNA expression of S1P re-
ceptor 1 and its major transcription factor KLF2 under nephritic
conditions (Figure 4D), suggesting a potential function of this re-
ceptor for the egress of Th17 cells from the gut.
Consequently, we induced cGN in Kaede-transgenic mice,
photoconverted intestinal cells at day four, and treated these
mice from day four to seven with FTY720 (Figure 4E), a functional
S1P receptor 1 agonist that arrests lymphocyte trafficking from
lymphoid organs into systemic circulation. FTY720 treatment
blocked the exit of CD4+ T cells from the small intestine (Figures
4F and 4G). Accordingly, the trafficking of Kaede red CD4+
T cells, including Th17 cells, from the intestine into the mesen-
teric lymph node (Figure 4H) and subsequently into the kidney
was significantly reduced (Figures 4I–4K). In contrast, by using
Kaede Ccr7/ mice, we demonstrated that the lack of Ccr7
affected neither the emigration of CD4+ T cells out of the gut
nor the migration of Th17 cells into the kidney (Figures 4F–4K).
Taken together, these experiments revealed that Th17 cell
egress from the small intestine is dependent on S1P receptor 1.
Of note, additional S1P receptor 1 blocking experiments
demonstrated that the FTY720 application significantly reduced
renal Th17 cell infiltration and subsequent kidney pathology in
nephritic mice (Figures S4A–S4D). These results further sup-
port—but due to the pleiotropic effect of FTY720, do not defini-
tively confirm—the therapeutic potential of blocking Th17-cell
gut egress in cGN.
CCR6/CCL20 Axis Guides the Trafficking of Intestinal
Th17 into the Inflamed Kidney
Following the exit from the gut, Th17 cells have to migrate via the
circulation into the kidney. Th17 cells in the kidney highly express
CCR6 (Figures 4L and 4M), which is accompanied by an upregu-
lated expression of its unique ligand CCL20 in the inflamed
kidney (Figure 4M). To find out whether the CCR6/CCL20 axis
regulates the trafficking of intestinal Th17 into the kidney,
nephritic Kaede mice were treated either with a neutralizing
anti-CCL20 antibody or an isotype control antibody. The traf-
ficking of photoconverted Th17 cells from the gut into the
nephritic kidney was significantly reduced in mice treated with
the anti-CCL20 antibody (Figures 4N and 4O). In contrast, Th1
cell recruitment was not affected (Figure 4N). Of note, anti-
CCL20 treatment did not affect the emigration of CD4+ Th17
cells from the small intestine (data not shown). Moreover,
CCL20 neutralization did not influence the clinical course of
cGN (Figures S4E–S4G). This is in line with a recent study
demonstrating that the CCL20/CCR6 axis also mediates renal
recruitment of Tregs, and that the reduction of anti-inflammatory
Tregs in the presence of a fully functional Th1 response aggra-
vates experimental glomerulonephritis (Turner et al., 2010).
Renal Th17 Cell Responses and Tissue Injury in cGN Is
Attenuated in Germ-Free Mice
To evaluate the functional impact of intestinal Th17 cells on
the course of Th17-driven experimental cGN, we induced
glomerulonephritis in C57BL/6 mice raised and kept under
germ-free (GF) or specific pathogen-free (SPF) conditions. The
absence of microbiota in GF mice (GFM) resulted in a deficiency
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Figure 3. Th17 Cells in Glomerulonephritis Migrate from the Intestine into the Kidney
(A) Experimental procedure: 4 days after cGN induction, photoconversion of the small intestine was performed, and at day 7, the kidneys were analyzed.
(B) Confocal microscopy of Kaede red+ cells in a renal tissue section of Kaede-tg mice (nucleus: DRAQ5-staining, blue).
(C) Flow cytometry of renal CD4+ T cells from Kaede-tg mice after cGN induction and photoconversion of the small intestine and controls. Kaede green+ cells and
Kaede red+ cells were assessed for IL-17A and IFN-g expression.
(D) Quantification of IL-17A and IFN-g expression in the respective Kaede population.
(E and F) Analysis and quantification of IL-17A and IFN-g expression in Kaede green+ and Kaede red+ gd T cells. Data are representative of three independent
experiments. Symbols represent individual data points, with the mean as a horizontal line.
*p < 0.05, ***p < 0.001. See also Figure S3.of intestinal Th17 cells (Figure 5A). Ten days after GN induction,
Th17 cells were reduced in the kidneys of nephritic GFM, while
the percentage of Th1 cells was unchanged (Figures 5B and
5C). In line, PAS-stained kidney sections revealed less glomer-
ular and tubular damage in nephritic GFM compared to SPF
mice (Figures 5D and 5E).
In contrast to the ameliorated course of GN in GFM, there was
no difference in renal Th17 responses (Figures S5A and S5B) orrenal tissue injury between nephritic mice and conventionally
colonized ex-GFM (Figure S5C).
Depletion of the Gut Microbiota by Broad-Spectrum
Antibiotics Ameliorates Th17 Cell Responses in cGN
To investigate whether the manipulation of gut microbiota in SPF
mice might prevent Th17-promoted kidney damage, we orally
treated mice with a cocktail of four antibiotics (ampicillin,Immunity 45, 1078–1092, November 15, 2016 1083
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Figure 4. Th17 Cells Egress from the Intestine in a S1P-Receptor-1-Dependent Fashion and Migrate to the Kidney via the CCL20/CCR6 Axis
in cGN
(A–C) Flow cytometry of T cells from the small intestinal lamina propria of Il17a fate reporter mice for CD44, CD69, CCR6, CD103, and CCR7 as indicated.
(D) RT-PCR analysis of FACS-sorting CD4+ Th17 cells from the small intestinal lamina propria of Il17a fate reporter mice. Error bars indicate SEM.
(E) After cGN induction in Kaede control (±FTY720 treatment day 3–7) and Kaede Ccr7/mice, intestinal cells were photoconverted and subsequently analyzed
for Kaede red+ CD4+ T cells.
(F–K) FACS analysis of intestinal (F and G), mesenteric lymph node (H), and renal (I–K) CD4+ T cells. See also Figures S4A–S4D.
(L) Renal Th17 cells from Il17a fate reporter mice at day 10 after cGN induction were analyzed for CCR6 expression by flow cytometry.
(M) Quantitative RT-PCR of CCL20 and CCR6 in the kidneys of mice after induction of cGN and control mice (n = 4 per group). Error bars indicate SEM.
(N and O) cGN was induced in Kaede-tg mice. From day 4 until 7, these mice received anti-CCL20monoclonal antibody or isotype control. Photoconversion was
performed at day 4. At day 7, renal CD4+ Kaede red+ T cells were analyzed for IL-17A and IFN-g expression.
See also Figure S4E–S4G. Data are representative of three independent experiments. Symbols represent individual data points, with themean as a horizontal line,
bars represent mean values. *p < 0.05, **p < 0.01, ***p < 0.001.metronidazole, neomycin, and vancomycin [AMNV]) prior cGN
induction. In line with a recent report (Horai et al., 2015), AMNV
treatment almost depleted the gut microbiota (Figure S6) and re-1084 Immunity 45, 1078–1092, November 15, 2016sulted in a reduced accumulation of Th17 cells in the small intes-
tine (Figure 5F). Even more important, the number of renal Th17
cells (Figures 5G and 5H), but not Th1 cells, and the subsequent
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Figure 5. Renal Th17 Response in cGN Is Dependent on Intestinal Microbiota
(A) Flow cytometry of CD4+ T cells from the small intestinal lamina propria of GFM and SPF mice after induction of cGN.
(B and C) Flow cytometry of renal CD4+ T cells for IL-17A and IFN-g expression.
(legend continued on next page)
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glomerular and tubulointerstitial injury were reduced (Figures 5I
and 5J).
Expansion of Intestinal Th17 Cells
in Citrobacter-Rodentium-Infected Mice Promotes
Renal Th17 Responses in cGN
Next, we infected nephritic mice at day 0 withCitrobacter roden-
tium that triggers a potent Th17 cell response in the gut (predom-
inantly in the colon and, to a lesser degree, in the small intestine)
seven days after oral challenge (Figure 6A) (Collins et al., 2014).
Flow-cytometric analysis revealed that, indeed, the Th17
response was markedly upregulated in the kidneys of nephritic
C.-rodentium-infected mice, while renal Th1 response and IL-
17A production by gd T cells were unchanged (Figures 6B and
6C). In accordance with the enhanced Th17 response, the
recruitment of neutrophils into the kidney was increased (Fig-
ure 6D). Moreover, C.-rodentium-infected mice developed a
moderately aggravated course of nephritis in terms of glomerular
crescent formation and tubulointerstitial injury (Figure 6E).
Therapeutic Manipulation of the Gut Microbiota with
Vancomycin Reduces Th17-Cell-Driven Injury in cGN
Finally, for a more specific therapeutic targeting of microbiota-
induced Th17 cells in the gut, we treated mice orally with the
glycopeptide antibiotic vancomycin (starting 4 weeks before
GN induction). Vancomycin is not absorbed in the intestine,
thus preventing major systemic side effects, and predomi-
nantly targets gram-positive bacteria, including Clostridia
species. To analyze intestinal microbiota composition after
vancomycin treatment, we applied amplicon sequencing. As
expected, vancomycin treatment, in contrast to a combination
of four antibiotics, which essentially eradicates the whole gut
microbiome (Figure S6), reduced the diversity of the intestinal
microbiota without depleting all commensal bacteria (Figures
7A and 7B). In particular, the family Clostridiales (phylum Firmi-
cutes), which has been previously shown to promote intestinal
Th17 cells (Ivanov et al., 2009), was reduced by this treatment.
Furthermore, increased abundance of Enterobacteriaceae,
Lactobacillaceae, and Verrucomicrobiaceae were detected
(Figure 7B). Of note, segmented filamentous bacteria were
not present.
Treatment with vancomycin was sufficient to selectively
decrease the number of Th17 cells in the small intestine (Figures
7C and 7D). As seen in nephritic GFM and nephritic mice treated
with broad-spectrum antibiotics, the diminished numbers of
Th17 cells in the gut resulted in a reduced recruitment of Th17
cells, but not Th1 cells, into the kidney (Figure 7E). Vancomy-
cin-treatment also reduced IL-17A expression by intestinal gd
T cells (Figures S7A and S7B) but did not affect IL-17A expres-
sion by renal gd T cells in cGN (Figures S7C and S7D). Accord-
ingly, renal mRNA expression analysis, using a cytokine- and(D) PAS staining of renal cortex from cGN and control mice. Scale bar, 20 mm.
(E) Glomerular crescent formation and tubulointerstitial damage (score) in the res
(F–J) Mice were treated with a combination of 4 antibiotics (AMNV) for 4 weeks prio
were analyzed for IL-17A and IFN-g. (H) Quantification of cytokine expression in r
and control mice. (J) Quantification of renal damage.
See also Figure S6. Data are representative of three independent experiments. Sy
bar, 20 mm. **p < 0.01.
1086 Immunity 45, 1078–1092, November 15, 2016chemokine-pathway-focused PCR array (RT2 Profiler), revealed
a predominant downregulation of Th17/IL-17A target genes in
vancomycin-treated mice (Figure S7E). Subsequent RT-PCR
analysis confirmed the reduced mRNA expression of the Th17
pathway, including the neutrophil chemoattractants CXCL1
and CXCL5 (Figure S7F). In line, we observed decreased neutro-
phil recruitment into the kidney (Figures 7F and 7G). No major
effect of vancomycin on the humoral immune response to the
nephritogenic antigen was detectable (Figures S7G–S7I). Van-
comycin-treated animals developed less severe disease in terms
of renal tissue injury (Figures 7H and 7I) and a better-preserved
kidney function as measured by blood urea nitrogen (BUN) and
albumin-to-creatinine ratio (ACR) (Figure 7J), highlighting the
therapeutic potential of this approach. Of note, vancomycin
application in nephritic Il17a/ mice had no effect on renal tis-
sue injury or neutrophil recruitment (Figures 7K–7M), indicating
that the ameliorated course of the disease in vancomycin-
treated mice is indeed Th17/IL-17A-dependent.
DISCUSSION
Rapidly progressive or cGN is the most aggressive form of
autoimmune kidney disease and remains a significant cause
of end-stage renal failure. Different disease entities may lead
to the development of cGN. The most common cause is
ANCA-associated small vessel vasculitis (Couser, 2012; Kurts
et al., 2013). Although there has been some progress in the
treatment of patients with cGN, the use of unspecific immuno-
suppressive or cytotoxic agents is still recommended in guide-
lines, illustrating the fact that more specific treatment options
based on the underlying immunopathogenic mechanisms are
clearly needed.
There is convincing evidence for a pathogenic role of Th17 cells
in murine models of crescentic and proliferative GN (Gan et al.,
2010; H€unemo¨rder et al., 2015; Krebs et al., 2013; Ooi et al.,
2009; Paust et al., 2012; Paust et al., 2009; Pisitkun et al., 2012;
Ramani et al., 2014; Steinmetz et al., 2011; Tulone et al., 2011),
but the translation of these findings into new therapeutic ap-
proaches has been hindered by the lack of robust data about
the role of the Th17 immune response in patients with cGN.
Our flow cytometric analysis revealed that CD4+RORgt+ Th17
cell frequencies were up to 30% in the kidney of ANCA-GN pa-
tients, which is higher than the reported frequencies inmost other
tissues affected by autoimmune diseases (Annunziato et al.,
2013). The local Th17 cell response promotes kidney injury by re-
cruiting neutrophils and other leukocyte subtypes to the target
tissue in mice (Disteldorf et al., 2015), and its presence in human
patients is a prerequisite for translating the findings gained from
animal models into clinical practice, for example, as successfully
done in IL-17A targeting for the treatment of psoriasis (Leonardi
et al., 2012; Mease et al., 2014).pective groups. See also Figure S5.
r to induction of cGN. (F) Small intestinal CD4+ T cells and (G) renal CD4+ T cells
enal CD4+ T cells. (I) PAS staining of renal cortex of mice with AMNV treatment
mbols represent individual data points, with themean as a horizontal line. Scale
AB
C
D
E
Figure 6. Expansion of Intestinal Th17 Cells by Citrobacter Rodentium Infection Aggravates Renal Th17 Immune Responses in cGN
(A) Flow cytometry of large intestine lamina propria CD4+ T cells after infection with Citrobacter rodentium and induction of cGN.
(B and C) (B) Renal CD4+ T cells and (C) renal gd T cells were analyzed for intracellular cytokine expression.
(D) GR-1 staining and quantification of neutrophil infiltration in the renal cortex from mice with cGN.
(E) Kidney damage was assessed by evaluation for glomerular crescents and tubulointerstitial damage in PAS-stained renal cortex sections. Scale bar, 25 mm.
Data are representative of three independent experiments. Symbols represent individual data points, with the mean as a horizontal line.*p < 0.05, **p < 0.01.The developmental origin of Th17 cells, promoting organ-spe-
cific autoimmunity, remains largely unexplored. Under homeo-
static conditions, Th17 cells are most abundant in the gut, wheretheir induction and accumulation depends on the gut microbiota
(Atarashi et al., 2015; Ivanov et al., 2008, 2009; Sano et al., 2015).
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microbes, e.g., SFB, and the lack of Th17 cells in GFM, have pro-
found effects on extra-intestinal autoimmune disorders (Lee
et al., 2011; Wu et al., 2010). This suggests a direct functional
relationship between microbiota-induced Th17 cells in the gut
and Th17-driven tissue injury at peripheral sites, e.g., the kidney.
To determine whether renal Th17 cells might be derived from
the gut, we induced the Th17-cell-dependent model of cGN
(Bolle´e et al., 2011; Krebs et al., 2013; Pisitkun et al., 2012; Tsu-
boi et al., 2008) in photoconvertible Kaede-transgenic mice
(Tomura et al., 2010). After photoconversion of cells in the small
intestine, we were able to detect a significant proportion of gut-
derived Th17 cells in the inflamed kidneys. Of note, due to tech-
nical limitations of the Kaede system that cannot be overcome at
present (e.g., photoconversion in the small intestine was not >
75%, did not include all segments of the gut, and covered only
a short period of time), our finding did not provide final evidence
that glomerulonephritis-driving Th17 cells are exclusively or pre-
dominantly derived from the gut. Using a related technical
approach, Morton et al. (2014) demonstrate the movement of
Th17 cells from the ascending colon into the spleen in arthritis-
prone K/BxNmice, andMackley et al. (2015) reveal a constitutive
trafficking of RORgt+ ILC3s from the intestine to the draining
mesenteric lymph nodes. Recently, Benakis et al. (2016) demon-
strate that antibiotic-induced alterations in the intestinal flora
reduce ischemic brain injury in mice, potentially as a conse-
quence of a reduction in meningeal IL-17-positive gd T cells.
The authors use photoconvertible KiK mice to track cells from
the gut, but they do not provide direct evidence for the migration
of IL-17-producing cells (gd T cells or CD4+ T cells) from the in-
testine to the CNS. In line with this report, we showed that target-
ing of the intestinal microbiota by vancomycin not only reduced
IL-17-producing CD4+ T cells but also IL-17A-producing gd
T cells in the gut. However, in contrast to the study by Benakis
et al. (2016), these interventions did not influence IL-17A-pro-
ducing gd T cells at extra-intestinal sites, namely the inflamed
kidney, supporting the idea that gd T cells in cGN predominantly
reside in the kidney and are not derived from the gut.
Our data provide direct evidence for the trafficking of Th17
cells from the gut to extra-intestinal sites of Th17-driven
inflammation. The trafficking of Th17 cells from the intestine
into the inflamed kidney in cGN required the exit from the
small intestinal lamina propria into the lymphatics and, subse-
quently, via the circulation into the kidney. Effector T cells
use S1P receptors to sense S1P gradients among blood,
tissues, and lymph, thereby guiding entry into efferent lym-
phatics during egress from lymphoid tissues (Baeyens et al.,
2015); however, whether this concept also applies for non-
lymphoid organs, e.g., the intestine, is less well characterized.
Here, we found that Th17 cell egress from the small intestine
was dependent on S1P receptor 1 and that their subsequent
trafficking into the inflamed kidney was mediated via the
CCL20/CCR6 axis.
Whether Th17 cells, generated in the intestine in response to
microbes, represent a general ‘‘reservoir’’ for Th17 cells, which
can be mobilized and migrate to distant sites of inflammation
in autoimmune or infectious diseases, remains to be fully
elucidated. Furthermore, it would be of great interest to study
whether circulating Th17 cells from the gut are recruited primarily
into the nephritic kidney via local chemoattractants or whether,1088 Immunity 45, 1078–1092, November 15, 2016in addition, so-far-unidentified kidney-derived signals might
mobilize Th17 cells to exit the gut.
The absence of intestinal Th17 cells in GFM and their depletion
in mice treated with broad-spectrum antibiotics resulted in a
reduced renal Th17 response and ameliorated the consecutive
tissue injury in glomerulonephritis. In contrast, expansion of in-
testinal Th17 cells in Citrobacter-rodentium-infected nephritic
mice exerted the opposite effect. Most importantly, further ex-
periments revealed that oral application of vancomycin alone
was sufficient to reduce microbiota-induced intestinal Th17 cells
and Th17 responses in the kidney, resulting in an ameliorated
course of cGN without any significant side effects, emphasizing
the great potential of this novel treatment strategy.
Before the manipulation of gut microbiota with, for example,
antibiotics is tested as a therapeutic strategy in Th17-cell-driven
human autoimmune disorders, a better understanding of the
interaction of the microbiome and Th17 cells in the human intes-
tine is clearly needed. But the finding that treatment with co-tri-
moxazole, given twice daily for 24months, prevented relapses in
patients with ANCA-associated vasculitis, in particular with up-
per respiratory disease (Stegeman et al., 1996), is of interest.
The mechanisms by which co-trimoxazole acts are still elusive,
but it suggests a possible therapeutic role for antimicrobial ther-
apy. Because this study was performed long before the first
identification of Th17 cells, the effect of co-trimoxazole on gut
microbiota and Th17 responses was not assessed.
EXPERIMENTAL PROCEDURES
Animals
Kaede-transgenic mice were obtained from M. Tomura (Kyoto University)
(Tomura et al., 2010). Il17a/ mice were provided by Y. Iwakura (University
of Tokyo). Ccr7/ and Tcra/ mice were from The Jackson Laboratory.
Il17aCRE 3 R26ReYFP mice have previously been described (Hirota et al.,
2011). Mice were on the C57BL/6J background and raised in SPF conditions.
GFM were raised and kept under sterile conditions (Steinhoff et al., 1999). All
animal experiments were approved by the local committees.
Animal Procedures
Experimental cGN was induced by i.p. injection of nephrotoxic sheep serum in
8- to 12-week-old male mice (Bolle´e et al., 2011; Krebs et al., 2013; Pisitkun
et al., 2012; Tsuboi et al., 2008). For photoconversion, the small intestine of
anesthetized Kaede-transgenic mice was subjected to lighting using a Blue
Wave LED Prime UVA (Dymax). For urine analyses, mice were housed in
metabolic cages for 5 hr, and urinary albuminwas determined by ELISA (Bethyl
Laboratories). ForCitrobacter rodentium infections, mice were inoculated with
200 mL of a bacterial suspension (109 CFU/mouse) via an oral gavage (Nagai
et al., 2005).
Interventional Studies
Mice were given either a combination of antibiotics (ampicillin 1 g/L, metroni-
dazole 1 g/L, neomycin 1 g/L, and vancomycin 0.5 g/L) or vancomycin alone
(0.5 g/L) by drinking water 4 weeks prior to the induction of cGN (Ivanov
et al., 2008; Rakoff-Nahoum et al., 2004). Anti-CCL20-antibody (clone
114908, R&D Systems) or isotype control (clone 43414, R&D Systems) were
used at 50 mg/day permouse (i.p.) at days 4, 5, and 6 after cGN induction (Kallal
et al., 2010). FTY720 was added to the drinking water at 5 mg/mL (Kursar et al.,
2008). FTY720 treatment was initiated 3 days after cGN induction and main-
tained until analysis.
Real-Time PCR Analyses
Total RNA of the renal cortex was prepared according to standard laboratory
methods. Real-time PCR was performed for 40 cycles on a StepOnePlus
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Figure 7. Manipulation of the Gut Microbiota with Vancomycin Ameliorates Th17-Cell-Driven Injury in cGN
Mice were treated for 4 weekswith vancomycin via the drinking water prior to induction of cGN. At day 10, mice were sacrificed, and stool samples were analyzed
by next-generation sequencing for microbiota abundance.
(A) Alpha diversity of microbiota abundance in mice with cGN, with and without vancomycin treatment.
(B) Abundance of bacteria on phylum level in mice after vancomycin treatment and control.
(C) Intestinal CD4+ T cells from mice with and without vancomycin treatment were analyzed for cytokine production.
(D and E) Quantification of IL-17A and IFN-g in (D) intestinal CD4+ T cells and (E) renal CD4+ T cells after vancomycin treatment.
(F and G) (F) GR-1 staining (scale bar, 50 mm) and (G) quantification of renal neutrophil infiltration.
(H and I) (H) PAS staining (scale bar, 25 mm) and (I) quantification of renal tissue damage in mice after vancomycin treatment and induction of cGN.
(J) BUN and albuminuria as functional parameters for kidney damage were measured in the respective groups. cGN induction was also assessed in vancomycin-
treated Il17a/ mice.
(legend continued on next page)
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Real-Time PCR system (Applied Biosystems) as previously described (Krebs
et al., 2013). All samples were run in duplicate and normalized to 18S rRNA.
Morphological Analyses
Glomerular injury and crescent formation, deposition of PAS-positive material,
and tubulointerstitial injury were assessed in PAS-stained renal tissue sections
(Krebs et al., 2013). Further morphological analyses are described in Supple-
mental Experimental Procedures.
Leukocyte Isolation and Transfer
For T cell transfer experiments, CD4+ T cells were isolated from kidneys of
Il17aCre 3 R26eYFP fate reporter mice at day 10 after induction of cGN or
from the small intestine of these mice without cGN. Cells were sorted on a
FACS Aria IIIa system (Krebs et al., 2013).
Flow Cytometry
Measurements were performed on a BD FACS LSR II or a BD LSR II Fortessa
(BD Biosciences), and data were analyzed with the FlowJo (Tree Star). Cells
were stained with antibodies from Biolegend, BD Biosciences, and eBio-
science. LIVE/DEAD staining (Thermo Fisher) was used to exclude dead cells.
For intracellular cytokine staining, cells were fixed and permeabilized using the
Cytofix/Cytoperm kit (BD Bioscience) or 3.7% PFA/0.1% Igepal in the case of
reporter mice (Hirota et al., 2011).
Analyses in Patients with ANCA-GN
Single-cell suspensions were obtained from human biopsies by enzymatic
digestion followed by dissociationwith gentleMACS (Miltenyi Biotec), antibody
staining, and flow cytometry (Paust et al., 2015). Analyses of human kidney
biopsies were approved by the local ethics committees (PV3162).
Sequencing Analysis
TCR sequencing of FACS-sorted cells from Il17a fate reporter mice (Il17aCre3
R26ReYFP) and 16S rRNA sequencing of murine feces is described in Supple-
mental Experimental Procedures.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (La Jolla). The re-
sults are shown as themean ± SEMwhen presented as a bar graph or as single
data points with the mean in a scatter dot plot. Differences between two indi-
vidual groups were compared using a two-tailed t test. In the case of three or
more groups, a one-way ANOVA with Bonferroni’s multiple comparisons test
was used.
ACCESSION NUMBERS
All 16S rRNA sequencing data are submitted to EMBL-EBI with the accession
number ENA: PRJEB15416.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2016.10.020.
AUTHORS CONTRIBUTIONS
C.F.K., H.-J.P., S.K., T.K., U.S., and U.P. planned and performed experiments
and analyses. C.F.K., J.-E.T., and U.P. designed the study and planned, as
well as supervised, the research. C.F.K. and U.P. wrote the manuscript.(K) Quantification of glomerular crescent formation and tubulointerstitial damage
(L) BUN and albuminuria in Il17a/ ± vancomycin-treatment.
(M) Quantification of renal neutrophil recruitment 10 days after nephritis inductio
Data are representative of three independent experiments. Symbols represent in
***p < 0.001, ****p < 0.0001.
See also Figure S7.
1090 Immunity 45, 1078–1092, November 15, 2016S.R.B., J.-H.R., P. Bartsch, T.W., N.F., J.H., P. Busch, H.-W.M., B.S.,
R.A.K.S., C.M.-S., U.O.W., L.G.P., M.J., O.M.S., N.G., and S.H. performed ex-
periments. C.F.K., J.-E.T., N.F., and U.P. analyzed the data and edited the
manuscript.ACKNOWLEDGMENTS
This study was supported by grants from the Deutsche Forschungsgemein-
schaft (SFB 1192 to U.P. and C.F.K.) and grants from the Deutsche Nierenstif-
tung and Deutsche Gesellschaft f€ur Nephrologie to C.F.K. T.K. received a
scholarship from the Werner-Otto-Foundation. FACS sorting was performed
at the UKE FACS sorting core facility.
Received: March 29, 2016
Revised: July 11, 2016
Accepted: September 27, 2016
Published: November 15, 2016
REFERENCES
Acosta-Rodriguez, E.V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M.,
Lanzavecchia, A., Sallusto, F., and Napolitani, G. (2007). Surface phenotype
and antigenic specificity of human interleukin 17-producing T helper memory
cells. Nat. Immunol. 8, 639–646.
Anderson, K.G., Mayer-Barber, K., Sung, H., Beura, L., James, B.R., Taylor,
J.J., Qunaj, L., Griffith, T.S., Vezys, V., Barber, D.L., and Masopust, D.
(2014). Intravascular staining for discrimination of vascular and tissue leuko-
cytes. Nat. Protoc. 9, 209–222.
Annunziato, F., Santarlasci, V., Maggi, L., Cosmi, L., Liotta, F., andRomagnani,
S. (2013). Reasons for rarity of Th17 cells in inflammatory sites of human dis-
orders. Semin. Immunol. 25, 299–304.
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M.,
Yagita, H., Ishii, N., Evans, R., Honda, K., and Takeda, K. (2008). ATP drives
lamina propria T(H)17 cell differentiation. Nature 455, 808–812.
Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S.,
Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. (2015). Th17 Cell
Induction by Adhesion of Microbes to Intestinal Epithelial Cells. Cell 163,
367–380.
Baeyens, A., Fang, V., Chen, C., and Schwab, S.R. (2015). Exit Strategies: S1P
Signaling and T Cell Migration. Trends Immunol. 36, 778–787.
Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Sita,
G., Racchumi, G., Ling, L., Pamer, E.G., et al. (2016). Commensal microbiota
affects ischemic stroke outcome by regulating intestinal gd T cells. Nat.
Med. 22, 516–523.
Bolle´e, G., Flamant, M., Schordan, S., Fligny, C., Rumpel, E., Milon, M.,
Schordan, E., Sabaa, N., Vandermeersch, S., Galaup, A., et al. (2011).
Epidermal growth factor receptor promotes glomerular injury and renal failure
in rapidly progressive crescentic glomerulonephritis. Nat. Med. 17, 1242–
1250.
Codarri, L., Gy€ulve´szi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L.,
Suter, T., and Becher, B. (2011). RORgt drives production of the cytokine GM-
CSF in helper T cells, which is essential for the effector phase of autoimmune
neuroinflammation. Nat. Immunol. 12, 560–567.
Collins, J.W., Keeney, K.M., Crepin, V.F., Rathinam, V.A., Fitzgerald, K.A.,
Finlay, B.B., and Frankel, G. (2014). Citrobacter rodentium: infection, inflam-
mation and the microbiota. Nat. Rev. Microbiol. 12, 612–623.of nephritic Il17a/ mice ± vancomycin-treatment (scale bar, 25 mm).
n.
dividual data points, with the mean as a horizontal line. *p < 0.05, **p < 0.01,
Couser, W.G. (2012). Basic and translational concepts of immune-mediated
glomerular diseases. J. Am. Soc. Nephrol. 23, 381–399.
Disteldorf, E.M., Krebs, C.F., Paust, H.J., Turner, J.E., Nouailles, G., Tittel, A.,
Meyer-Schwesinger, C., Stege, G., Brix, S., Velden, J., et al. (2015). CXCL5
drives neutrophil recruitment in TH17-mediated GN. J. Am. Soc. Nephrol.
26, 55–66.
Esplugues, E., Huber, S., Gagliani, N., Hauser, A.E., Town, T., Wan, Y.Y.,
O’Connor, W., Jr., Rongvaux, A., Van Rooijen, N., Haberman, A.M., et al.
(2011). Control of TH17 cells occurs in the small intestine. Nature 475,
514–518.
Gaffen, S.L., Jain, R., Garg, A.V., andCua, D.J. (2014). The IL-23-IL-17 immune
axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14,
585–600.
Gan, P.Y., Steinmetz, O.M., Tan, D.S., O’Sullivan, K.M., Ooi, J.D., Iwakura, Y.,
Kitching, A.R., and Holdsworth, S.R. (2010). Th17 cells promote autoimmune
anti-myeloperoxidase glomerulonephritis. J. Am. Soc. Nephrol. 21, 925–931.
Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy,
K.M., and Weaver, C.T. (2005). Interleukin 17-producing CD4+ effector T cells
develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat.
Immunol. 6, 1123–1132.
Hirota, K., Duarte, J.H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D.J., Ahlfors, H.,
Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011). Fate mapping of IL-17-pro-
ducing T cells in inflammatory responses. Nat. Immunol. 12, 255–263.
Hirota, K., Turner, J.E., Villa, M., Duarte, J.H., Demengeot, J., Steinmetz, O.M.,
and Stockinger, B. (2013). Plasticity of Th17 cells in Peyer’s patches is respon-
sible for the induction of T cell-dependent IgA responses. Nat. Immunol. 14,
372–379.
Horai, R., Za´rate-Blade´s, C.R., Dillenburg-Pilla, P., Chen, J., Kielczewski, J.L.,
Silver, P.B., Jittayasothorn, Y., Chan, C.C., Yamane, H., Honda, K., and Caspi,
R.R. (2015). Microbiota-Dependent Activation of an Autoreactive T Cell
Receptor Provokes Autoimmunity in an Immunologically Privileged Site.
Immunity 43, 343–353.
H€unemo¨rder, S., Treder, J., Ahrens, S., Schumacher, V., Paust, H.J., Menter,
T., Matthys, P., Kamradt, T., Meyer-Schwesinger, C., Panzer, U., et al. (2015).
TH1 and TH17 cells promote crescent formation in experimental autoimmune
glomerulonephritis. J. Pathol. 237, 62–71.
Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille,
J.J., Cua, D.J., and Littman, D.R. (2006). The orphan nuclear receptor
RORgammat directs the differentiation program of proinflammatory IL-17+ T
helper cells. Cell 126, 1121–1133.
Ivanov, I.I., Frutos, Rde.L., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B.,
Finlay, B.B., and Littman, D.R. (2008). Specific microbiota direct the differen-
tiation of IL-17-producing T-helper cells in the mucosa of the small intestine.
Cell Host Microbe 4, 337–349.
Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D.,
Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal
Th17 cells by segmented filamentous bacteria. Cell 139, 485–498.
Kallal, L.E., Schaller, M.A., Lindell, D.M., Lira, S.A., and Lukacs, N.W. (2010).
CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment
of DC. Eur. J. Immunol. 40, 1042–1052.
Kitching, A.R., and Holdsworth, S.R. (2011). The emergence of TH17 cells as
effectors of renal injury. J. Am. Soc. Nephrol. 22, 235–238.
Krebs, C.F., Kapffer, S., Paust, H.J., Schmidt, T., Bennstein, S.B., Peters, A.,
Stege, G., Brix, S.R., Meyer-Schwesinger, C., M€uller, R.U., et al. (2013).
MicroRNA-155 drives TH17 immune response and tissue injury in experi-
mental crescentic GN. J. Am. Soc. Nephrol. 24, 1955–1965.
Kursar, M., J€anner, N., Pfeffer, K., Brinkmann, V., Kaufmann, S.H., and
Mittr€ucker, H.W. (2008). Requirement of secondary lymphoid tissues for the
induction of primary and secondary T cell responses against Listeria mono-
cytogenes. Eur. J. Immunol. 38, 127–138.
Kurts, C., Panzer, U., Anders, H.J., and Rees, A.J. (2013). The immune system
and kidney disease: basic concepts and clinical implications. Nat. Rev.
Immunol. 13, 738–753.Lee, Y.K., Menezes, J.S., Umesaki, Y., and Mazmanian, S.K. (2011).
Proinflammatory T-cell responses to gut microbiota promote experimental
autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108 (Suppl 1 ),
4615–4622.
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia,
E., Braun, D., and Banerjee, S. (2012). Anti-interleukin-17monoclonal antibody
ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366, 1190–1199.
Mackley, E.C., Houston, S., Marriott, C.L., Halford, E.E., Lucas, B., Cerovic, V.,
Filbey, K.J., Maizels, R.M., Hepworth, M.R., Sonnenberg, G.F., et al. (2015).
CCR7-dependent trafficking of RORg+ ILCs creates a unique microenviron-
ment within mucosal draining lymph nodes. Nat. Commun. 6, 5862.
Mease, P.J., Genovese, M.C., Greenwald, M.W., Ritchlin, C.T., Beaulieu, A.D.,
Deodhar, A., Newmark, R., Feng, J., Erondu, N., and Nirula, A. (2014).
Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis.
N. Engl. J. Med. 370, 2295–2306.
Morton, A.M., Sefik, E., Upadhyay, R., Weissleder, R., Benoist, C., andMathis,
D. (2014). Endoscopic photoconversion reveals unexpectedly broad leukocyte
trafficking to and from the gut. Proc. Natl. Acad. Sci. USA 111, 6696–6701.
Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L.
(1986). Two types of murine helper T cell clone. I. Definition according to pro-
files of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–
2357.
Nagai, T., Abe, A., and Sasakawa, C. (2005). Targeting of enteropathogenic
Escherichia coli EspF to host mitochondria is essential for bacterial pathogen-
esis: critical role of the 16th leucine residue in EspF. J. Biol. Chem. 280, 2998–
3011.
Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L.,
Schluns, K., Tian, Q., Watowich, S.S., Jetten, A.M., and Dong, C. (2007).
Essential autocrine regulation by IL-21 in the generation of inflammatory
T cells. Nature 448, 480–483.
O’Shea, J.J., and Paul, W.E. (2010). Mechanisms underlying lineage commit-
ment and plasticity of helper CD4+ T cells. Science 327, 1098–1102.
Ooi, J.D., Phoon, R.K., Holdsworth, S.R., and Kitching, A.R. (2009). IL-23, not
IL-12, directs autoimmunity to the Goodpasture antigen. J. Am. Soc. Nephrol.
20, 980–989.
Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y.,
Hood, L., Zhu, Z., Tian, Q., and Dong, C. (2005). A distinct lineage of CD4
T cells regulates tissue inflammation by producing interleukin 17. Nat.
Immunol. 6, 1133–1141.
Paust, H.J., Turner, J.E., Steinmetz, O.M., Peters, A., Heymann, F., Ho¨lscher,
C., Wolf, G., Kurts, C., Mittr€ucker, H.W., Stahl, R.A., and Panzer, U. (2009). The
IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis.
J. Am. Soc. Nephrol. 20, 969–979.
Paust, H.J., Turner, J.E., Riedel, J.H., Disteldorf, E., Peters, A., Schmidt, T.,
Krebs, C., Velden, J., Mittr€ucker, H.W., Steinmetz, O.M., et al. (2012).
Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune
responses in murine crescentic glomerulonephritis. Kidney Int. 82, 72–83.
Paust, H.J., Riedel, J.H., Krebs, C.F., Turner, J.E., Brix, S.R., Krohn, S., Velden,
J., Wiech, T., Kaffke, A., Peters, A., et al. (2015). CXCR3+ Regulatory T Cells
Control TH1 Responses in Crescentic GN. J Am Soc Nephrol.
Pisitkun, P., Ha, H.L., Wang, H., Claudio, E., Tivy, C.C., Zhou, H., Mayadas,
T.N., Illei, G.G., and Siebenlist, U. (2012). Interleukin-17 cytokines are critical
in development of fatal lupus glomerulonephritis. Immunity 37, 1104–1115.
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and
Medzhitov, R. (2004). Recognition of commensal microflora by toll-like recep-
tors is required for intestinal homeostasis. Cell 118, 229–241.
Ramani, K., Pawaria, S., Maers, K., Huppler, A.R., Gaffen, S.L., and Biswas,
P.S. (2014). An essential role of interleukin-17 receptor signaling in the devel-
opment of autoimmune glomerulonephritis. J. Leukoc. Biol. 96, 463–472.
Riedel, J.H., Paust, H.J., Krohn, S., Turner, J.E., Kluger, M.A., Steinmetz, O.M.,
Krebs, C.F., Stahl, R.A., and Panzer, U. (2016). IL-17F Promotes Tissue Injury
in Autoimmune Kidney Diseases. J. Am. Soc. Nephrol. Published online March
30, 2016. http://dx.doi.org/10.1681/ASN.2015101077.Immunity 45, 1078–1092, November 15, 2016 1091
Sano, T., Huang, W., Hall, J.A., Yang, Y., Chen, A., Gavzy, S.J., Lee, J.Y., Ziel,
J.W., Miraldi, E.R., Domingos, A.I., et al. (2015). An IL-23R/IL-22 Circuit
Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17
Responses. Cell 163, 381–393.
Stegeman, C.A., Tervaert, J.W., de Jong, P.E., and Kallenberg, C.G.; Dutch
Co-Trimoxazole Wegener Study Group (1996). Trimethoprim-sulfamethoxa-
zole (co-trimoxazole) for the prevention of relapses of Wegener’s granuloma-
tosis. N. Engl. J. Med. 335, 16–20.
Steinhoff, U., Brinkmann, V., Klemm, U., Aichele, P., Seiler, P., Brandt, U.,
Bland, P.W., Prinz, I., Z€ugel, U., and Kaufmann, S.H. (1999). Autoimmune in-
testinal pathology induced by hsp60-specific CD8 T cells. Immunity 11,
349–358.
Steinmetz, O.M., Summers, S.A., Gan, P.Y., Semple, T., Holdsworth, S.R., and
Kitching, A.R. (2011). The Th17-defining transcription factor RORgt promotes
glomerulonephritis. J. Am. Soc. Nephrol. 22, 472–483.
Summers, S.A., Steinmetz, O.M., Li, M., Kausman, J.Y., Semple, T., Edgtton,
K.L., Borza, D.B., Braley, H., Holdsworth, S.R., and Kitching, A.R. (2009). Th1
and Th17 cells induce proliferative glomerulonephritis. J. Am. Soc. Nephrol.
20, 2518–2524.
Tomura, M., Honda, T., Tanizaki, H., Otsuka, A., Egawa, G., Tokura, Y.,
Waldmann, H., Hori, S., Cyster, J.G., Watanabe, T., et al. (2010). Activated reg-
ulatory T cells are the major T cell type emigrating from the skin during a cuta-
neous immune response in mice. J. Clin. Invest. 120, 883–893.1092 Immunity 45, 1078–1092, November 15, 2016Tsuboi, N., Asano, K., Lauterbach, M., and Mayadas, T.N. (2008). Human
neutrophil Fcgamma receptors initiate and play specialized nonredundant
roles in antibody-mediated inflammatory diseases. Immunity 28, 833–846.
Tulone, C., Giorgini, A., Freeley, S., Coughlan, A., and Robson, M.G. (2011).
Transferred antigen-specific T(H)17 but not T(H)1 cells induce crescentic
glomerulonephritis in mice. Am. J. Pathol. 179, 2683–2690.
Turner, J.E., Paust, H.J., Steinmetz, O.M., Peters, A., Riedel, J.H., Erhardt, A.,
Wegscheid, C., Velden, J., Fehr, S., Mittr€ucker, H.W., et al. (2010). CCR6 re-
cruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.
J. Am. Soc. Nephrol. 21, 974–985.
Wu, H.J., Ivanov, I.I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman,
D.R., Benoist, C., and Mathis, D. (2010). Gut-residing segmented filamentous
bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32,
815–827.
Yang, Y., Torchinsky, M.B., Gobert, M., Xiong, H., Xu, M., Linehan, J.L.,
Alonzo, F., Ng, C., Chen, A., Lin, X., et al. (2014). Focused specificity of in-
testinal TH17 cells towards commensal bacterial antigens. Nature 510,
152–156.
Zenewicz, L.A., Yancopoulos, G.D., Valenzuela, D.M., Murphy, A.J., Karow,
M., and Flavell, R.A. (2007). Interleukin-22 but not interleukin-17 provides
protection to hepatocytes during acute liver inflammation. Immunity 27,
647–659.
